Class IA PI3Ks (phosphoinositide 3-kinases) generate the secondary messenger PtdIns(3,4,5)P 3 , which plays an important role in many cellular responses. The accumulation of PtdIns(3,4,5)P 3 in cell membranes is routinely measured using GFP (green fluorescent protein)-labelled PH (pleckstrin homology) domains. However, the kinetics of membrane PtdIns(3,4,5)P 3 synthesis and turnover as detected by PH domains have not been validated using an independent method. In the present study, we measured EGF (epidermal growth factor)-stimulated membrane PtdIns(3,4,5)P 3 production using a specific monoclonal anti-PtdIns(3,4,5)P 3 antibody, and compared the results with those obtained using PH-domain-dependent methods. Anti-PtdIns(3,4,5)P 3 staining rapidly accumulated at the leading edge of EGF-stimulated carcinoma cells. PtdIns(3,4,5)P 3 levels were maximal at 1 min, and returned to basal levels by 5 min. In contrast, membrane PtdIns(3,4,5)P 3 production, measured by the membrane translocation of an epitope-tagged BTK PH (PH domain of Bruton's tyrosine kinase), remained approx. 2-fold above basal level throughout 4-5 min of EGF stimulation. To determine the reason for this disparity, we measured the rate of PtdIns(3,4,5)P 3 hydrolysis by measuring the decay of the PtdIns(3,4,5)P 3 signal after LY294002 treatment of EGF-stimulated cells. LY294002 abolished anti-PtdIns(3,4,5)P 3 membrane staining within 10 s of treatment, suggesting that PtdIns(3,4,5)P 3 turnover occurs within seconds of synthesis. In contrast, BTK PH membrane recruitment, once initiated by EGF, was relatively insensitive to LY294002. These data suggest that sequestration of PtdIns(3,4,5)P 3 by PH domains may affect the apparent kinetics of PtdIns(3,4,5)P 3 accumulation and turnover; consistent with this hypothesis, we found that GRP-1 (general receptor for phosphoinositides 1) PH domains [which, like BTK, are specific for PtdIns(3,4,5)P 3 ] inhibit PTEN (phosphatase and tensin homologue deleted on chromosome 10) dephosphorylation of PtdIns(3,4,5)P 3 in vitro. These data suggest that anti-PtdIns(3,4,5)P 3 antibodies are a useful tool to detect localized PtdIns(3,4,5)P 3 , and illustrate the importance of using multiple approaches for the estimation of membrane phosphoinositides.
INTRODUCTION
PI3Ks (phosphoinositide 3-kinases) are key regulators of many cellular responses. The class I PI3Ks, which include both receptor tyrosine kinase-activated (class IA) and trimeric G-proteinactivated (class IB) enzymes, produce primarily PtdIns(3,4,5)P 3 in intact cells. Production of this lipid in cellular membranes is thought to recruit and/or activate downstream signalling proteins, including serine/threonine protein kinases such as PDK1 (phosphoinositide-dependent kinase 1) and Akt [1] , tyrosine kinase such as BTK (Bruton's tyrosine kinase) [2] , guaninenucleotide-exchange factors such as Vav1, ARNO [ARF (ADPribosylation factor) nucleotide-binding-site opener] and GRP-1 (general receptor for phosphoinositides 1) [3] [4] [5] .
The analysis of phosphoinositide synthesis and localization has, in the last few years, been dominated by the use of GFP (green fluorescent protein)-PH (pleckstrin homology) domain fusions. Most PH domains show low lipid-binding specificity [6, 7] . However, the few PH domains that show relatively high specificity, such as the PLCδ1 (phospholipase Cδ1) PH domain (  PLCδ1 PH) for PtdIns(4,5)P 2 , or the BTK and GRP-1 PH domains for PtdIns(3,4,5)P 3 [8] [9] [10] , have been used extensively as probes for phosphoinositide localization. However, these probes appear to provide a rather selective view of phosphoinositide localization. For example, as noted by Balla et al. [11] , probes using PLCδ1 PH show almost exclusive localization to the plasma membrane, despite the fact that the presence of PtdIns(4,5)P 2 in the Golgi and in secretory vesicles is well established. Furthermore, Yu et al. [7] note that, in yeast, the phosphoinositide-binding specificity of distinct PH domains is not predictive of their localization. Finally, Balla et al. [11] showed that, despite the fact that the resynthesis of PtdIns(4,5)P 2 in ionomycin-treated cells is sensitive to micromolar concentrations of wortmannin, the localization of PLCδ1 PH-GFP is not. Thus it is important to verify the results obtained with PH domain probes with other methods for the analysis of phosphoinositide localization.
In the present study, we have used a recently developed anti-PtdIns(3,4,5)P 3 antibody (Echelon Biosciences) to analyse PtdIns(3,4,5)P 3 dynamics at the leading edge of EGF (epidermal growth factor)-stimulated carcinoma cells. This antibody shows Abbreviations used: BTK, Bruton's tyrosine kinase; di-C 8 , di-octanoyl; EGF, epidermal growth factor; GFP, green fluorescent protein; GRP-1, general receptor for phosphoinositides 1; GST, glutathione transferase; PH, pleckstrin homology; PI3K, phosphoinositide 3-kinase; PLC, phospholipase C; PTEN, phosphatase and tensin homologue deleted on chromosome 10; Sos, Son of sevenless. 1 Present address: Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, U.S.A. 2 To whom correspondence should be addressed (email backer@aecom.yu.edu).
highly specific binding to PtdIns(3,4,5)P 3 in situ. When we compared different methods of PtdIns(3,4,5)P 3 detection, we found that both antibody-staining and PH-domain-mediated methods showed similar kinetics of PtdIns(3,4,5)P 3 accumulation, but the persistence of the signal was much greater with the PH domain probe. Consistent with this finding, we observed that the half-life of PtdIns(3,4,5)P 3 measured by antibody staining is significantly shorter than that detected by PH domain localization, and we found that PH domains from GRP-1, which binds specifically to PtdIns(3,4,5)P 3 [12, 13] , inhibit PTEN (phosphatase and tensin homologue deleted on chromosome 10) dephosphorylation of PtdIns(3,4,5)P 3 in vitro. Our data point to pitfalls in the exclusive use of PH-domain-mediated methods to detect PtdIns(3,4,5)P 3 levels, and show that immunostaining methods are a valuable additional approach for quantification and localization of intracellular PtdIns(3,4,5)P 3 .
EXPERIMENTAL

Materials
Monoclonal anti-PtdIns(3,4,5)P 3 antibodies were a gift from Echelon Bioscience. Anti-pSer 473 antibodies were purchased from Upstate Biotechnology. Monoclonal anti-Myc antibodies (clone 4E-10; A.T.C.C., Manassas, VA, U.S.A.) were isolated from mouse ascites. Wortmannin and LY294002 were obtained from Calbiochem. A construct expressing GFP-PTEN (wild-type or catalytically inactive) was a gift from Dr Peter Downes (Department of Biochemistry, University of Dundee, Dundee, U.K.). Recombinant PH domains from GRP-1 were produced in house by Echelon Biosciences. A construct for the dynamin PH (PH domain from dynamin) was provided by Dr Mark Lemmon (Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA, U.S.A.).
dynamin PH was produced in bacteria as a GST (glutathione transferase) fusion, purified with glutathioneSepharose beads and cleaved from GST with thrombin.
Cell culture and EGF stimulation
The rat mammary adenocarcinoma breast cancer cell line, MTLn3, has been described previously [14] . Before EGF stimulation, MTLn3 cells were starved in L15 medium (Gibco BRL) supplemented with 0.35 % BSA in a 37
• C non-CO 2 incubator for 3-4 h. EGF stimulations used a final concentration of 5 nM EGF (Upstate Biotechnology) and were performed in a 37
• C water bath [14] .
Constructs and transient transfection
The GFP/Myc-tagged BTK PH (PH domain of BTK) construct was obtained from Dr Skolnik (Skirball Institute of Biomolecular Medicine, New York University Medical Center, New York, NY, U.S.A.). Transient transfection of MTLn3 cells were performed using Lipofectamine TM Plus reagents (Invitrogen). After 48 h, BTK PH-transfected cells were quiesced, stimulated with EGF for various times, fixed and immunostained with monoclonal antiMyc antibody.
Quantitative fluorescence microscopy
Cells were plated on collagen-coated coverslips 24 h before the experiment. EGF-stimulated cells were fixed rapidly and permeabilized in 3.7 % (w/v) paraformaldehyde and 0.1 % glutaraldehyde in 0.15 mg/ml saponin solution prepared in fix buffer (5 mM KCl, 137 mM NaCl, 4 mM NaHCO 3 , 0.4 mM KH 2 PO 4 , 1.1 mM Na 2 HPO 4 , 2 mM MgCl 2 , 5 mM Pipes, pH 7.2, 2 mM EGTA and 5.5 mM glucose) for 1 h at 37
• C. The fixed cells were incubated with primary antibodies for 1 h, followed by secondary antibodies for 45 min, and mounted in 6 mg/ml npropylgallate prepared in 50 % (v/v) glycerol in PBS. All fluorescence images were obtained using a 60× 1.4 NA (numerical aperture) Olympus objective and a cooled CCD (charge-coupled device) camera. We have shown previously, using atomic force microscopy, that the height of the lamellipod in EGF-stimulated MTLn3 cells is approx. 600-800 nm [15] . Thus the entire lamellipod is within one optical section and the use of confocal microscopy was not necessary. For fluorescence quantification, digital images were imported into NIH Image software and analysed using a previously described macro [16] . This macro collects pixel intensities from the perimeter of the cell in a 0.22 μm stepwise manner. The pixel intensities in the leadingedge compartment, defined as the first three slices (0.66 μm) from the perimeter of the cells, were averaged and normalized to the edge intensity of non-stimulated cells.
Analysis of endogenous PtdIns(3,4,5)P 3 production
MTLn3 cells were cultured in inositol-free medium for 4 days, then labelled with myo- [ 3 H]inositol (PerkinElmer) for 2 days. The cells were starved in serum-free medium for 4 h, then stimulated with EGF for various times. Lipids were extracted and deacylated as described by Stephens et al. [17] , and glycerophosphoinositides were analysed by anion-exchange HPLC using a Partisil-SAX column as described by Auger et al. [18] . PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 standards were prepared by deacylation of 3 Hlabelled PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 , the latter produced in vitro with recombinant p85/p110.
PI3K-inhibition assays
MTLn3 cells were stimulated with EGF for 1 min, then washed rapidly with warm medium containing either 0.1 % DMSO or 20 μM LY294002 in the continued presence of 5 nM EGF. After various times of drug treatment, the cells were permeabilized, fixed and stained as described above.
PTEN assays
Di-C 8 (di-octanoyl) PtdIns(3,4,5)P 3 substrate (1500 pmol/point) was diluted in assay buffer [Tris-buffered saline containing 31 mM DTT (dithiothreitol)], then combined with the indicated concentrations of purified PH domain protein and incubated for 15 min at room temperature (22 • C) on an orbital plate shaker. PTEN reactions were initiated by adding 110 ng of recombinant PTEN, mixing for 1 min, then incubating at 37
• C for an additional 14 min. Reactions were terminated by the addition of Malachite Green solution, and the colour was developed for 15 min before measuring the absorbance at 620 nm using a SPECTRAmax plate reader. Background (no PTEN) values were subtracted from each measurement. Each protein concentration was assayed in duplicate, and the experiment was repeated five times with similar results using comparable controls.
RESULTS
Specific detection of EGF-stimulated PtdIns(3,4,5)P 3 production in MTLn3 cells
We used a monoclonal anti-PtdIns(3,4,5)P 3 antibody to measure the spatial and the temporal distribution of endogenous PtdIns(3,4,5)P 3 in EGF-stimulated rat adenocarcinoma cells (MTLn3). To confirm the specificity of the anti-PtdIns(3,4,5)P 3 antibody, we pre-absorbed the antibody with PtdIns, PtdIns(4,5)P 2 or PtdIns(3,4,5)P 3 lipid vesicles at 4
• C for 1 h before cell staining. We found that incubation of the anti-PtdIns(3,4,5)P 3 antibody with PtdIns(3,4,5)P 3 -containing vesicles abolished membrane staining of EGF-stimulated MTLn3 cells (Figures 1A, lowerleft panel, and 1B). In contrast, incubation with PtdIns or PtdIns(4,5)P 2 vesicles had no effect on PtdIns(3,4,5)P 3 staining (Figures 1A, upper-left and upper-right panels respectively, and 1B). This is a particularly important control, as PtdIns(4,5)P 2 levels in cells are 200-fold higher than PtdIns(3,4,5)P 3 levels [19] . Quantification of PtdIns(3,4,5)P 3 staining after pre-absorption with various mono-and di-phosphoinositides showed that the anti-PtdIns(3,4,5)P 3 antibody was unaffected by PtdIns, PtdIns(3)P, PtdIns(4)P or PtdIns(4,5)P 2 vesicles ( Figure 1B ). Although incubation with PtdIns(3,4)P 2 vesicles slightly reduced the PtdIns(3,4,5)P 3 staining, the reduction was not statistically significant ( Figure 1B) . PtdIns(3,4,5)P 3 staining was also abolished in wortmannin-treated cells ( Figure 1A , lower-right panel, and Figure 1B ). Finally, anti-PtdIns(3,4,5)P 3 staining was markedly diminished in cells overexpressing GFP-tagged PTEN (Figure 1C) ; expression of a catalytically inactive mutant of PTEN had no effect on PtdIns(3,4,5)P 3 staining (results not shown). Our results show that the anti-PtdIns(3,4,5)P 3 antibody is specific, and has minimal cross-reactivity with either PtdIns or PtdIns(4,5)P 2 , which are the most abundant phosphoinositides in mammalian cells.
Kinetics of EGF-induced PtdIns(3,4,5)P 3 production at the leading edge of the lamellipod
We have recently examined the kinetics of PtdIns(3,4,5)P 3 production in EGF-stimulated MTLn3 cells using the antiPtdIns(3,4,5)P 3 antibody [20] . These cells respond to EGF by producing a broad flat ruffle-free lamellipod, whose height is approx. 0.5 μm [15] . Protrusion is maximal by 3 min, and is driven by the PI3K-dependent polymerization of actin filaments at the leading edge of the protruding cell [14, 21, 22] . In quiescent MTLn3 cells, membrane-associated PtdIns(3,4,5)P 3 is not detected (Figure 2A , left-hand panel). However, after EGF stimulation, the anti-PtdIns(3,4,5)P 3 antibody detected a narrow band of punctate staining at the cell periphery (Figure 2A , righthand panel). As noted previously [20] , quantification of the edge fluorescence intensity (0.66 μm from the periphery of the cell) showed that EGF-stimulated PtdIns(3,4,5)P 3 production showed a sharp peak at 1 min. PtdIns(3,4,5)P 3 staining at the edge was still detectable at 3 min, when the protrusion of the lamellipod is maximal [14, 21] . Anti-PtdIns(3,4,5)P 3 staining was markedly reduced at 4 min and returned to basal level by 5 min. Our results show that EGF-stimulated PtdIns(3,4,5)P 3 production is rapid, with maximal levels at 1 min, and declines to basal levels by 4-5 min, after the peak of MTLn3 protrusion [14, 20] . A similar profile was obtained when PtdIns(3,4,5)P 3 production was measured by HPLC analysis of deacylated lipids extracted from myo- [ 3 H]inositol-labelled cells, with PtdIns(3,4,5)P 3 levels maximal at 1 min of EGF stimulation. We were unable to detect the increased PtdInsP 3 at 3 and 5 min, presumably due to the lesser sensitivity of detection by metabolic labelling compared with the antibody-based method.
To measure PtdIns(3,4,5)P 3 production at the leading edge of EGF-stimulated cells using another independent method, MTLn3 cells were transfected with GFP/Myc-tagged BTK PH, which has high binding specificity for PtdIns(3,4,5)P 3 [8, 9] . The cells were stimulated, fixed and immunostained with anti-Myc antibody. In quiescent MTLn3 cells, anti-Myc staining was cytosolic and largely excluded from the cell periphery ( Figure 2C , left-hand panel).
BTK PH was rapidly recruited to the leading edge of EGFstimulated cells, where the maximal edge intensity occurred at 50 s after stimulation ( Figures 2C and 2D) . However, unlike the data obtained with anti-PtdIns(3,4,5)P 3 staining or metabolic labelling, which show a sharp peak of PtdInsP 3 followed by a decline to basal levels, a sustained elevation of BTK PH at the cell edge was observed throughout 5 min of EGF stimulation ( Figures 2C and 2D ).
Kinetics of PtdIns(3,4,5)P 3 hydrolysis
The production of PtdIns(3,4,5)P 3 at the leading edge of EGFstimulated carcinoma cells was detected within 1 min, and persists for up to 3 min or more than 5 min, depending on the detection method used. This could reflect the time course of PI3K activity in MTLn3 cells. Alternatively, persistent PtdIns(3,4,5)P 3 levels could be due to slow hydrolysis of PtdIns(3,4,5)P 3 . To distinguish these possibilities, a reversible PI3K inhibitor, LY294002, was used to inhibit PI3K activity in EGF-stimulated cells. Although LY294002 is less specific than wortmannin [23] , it was chosen for these experiments for its rapid onset of inhibition, and because the experiment focuses directly on PtdIns(3,4,5)P 3 , rather than on downstream signalling. MTLn3 cells were stimulated with EGF for 1 min, a time when PtdIns(3,4,5)P 3 production is maximal. The medium was then rapidly replaced with warm medium containing EGF plus LY294002 or carrier. At various times, the cells were then fixed, and PtdIns(3,4,5)P 3 production was measured by staining with anti-PtdIns(3,4,5)P 3 antibodies. Leading-edge anti-PtdIns(3,4,5)P 3 staining in carrier-treated cells ( Figure 3B , left-hand panels) was similar to that in untreated cells ( Figure 3A) . In contrast, the intensity of antiPtdIns(3,4,5)P 3 staining decreased rapidly after LY294002 treatment ( Figure 3B , right-hand panels). Higher magnification of these images showed that treatment of cells with LY294002 significantly attenuated leading-edge PtdIns(3,4,5)P 3 levels within 10 s ( Figure 3C ). Quantification of the leading-edge fluorescence intensity showed that membrane PtdIns(3,4,5)P 3 levels were reduced to ∼ 18 % of maximal after 10 s of LY294002 treatment, whereas membrane PtdIns(3,4,5)P 3 in carrier-treated cells remained within ∼ 80-100 % of maximal. After 60 s of LY294002 treatment, leading-edge PtdIns(3,4,5)P 3 staining was completely abolished (Figure 3D ), whereas PtdIns(3,4,5)P 3 levels in carrier-treated cells were at ∼ 30-40 % of maximal. This latter value is consistent with the kinetics of EGF-stimulated PtdIns(3,4,5)P 3 production in untreated cells ( Figure 2B ). These results indicate that EGF-stimulated membrane PtdIns(3,4,5)P 3 turnover is extremely fast, and that the sustained elevation of leading-edge PtdIns(3,4,5)P 3 in untreated cells requires persistent PI3K activity. We next examined the rate of PtdIns(3,4,5)P 3 hydrolysis as detected by the PH-domain membrane translocation assays. BTK PH-transfected cells were stimulated with EGF for 1 min, then treated with LY294002 or carrier in the presence of continuing EGF stimulation.
BTK PH was recruited rapidly to the plasma membrane of EGF-stimulated cells ( Figure 3E ). Unlike immunostaining of leading-edge PtdIns(3,4,5)P 3 production, membrane localization of BTK PH was relative insensitive to LY294002 ( Figure 3F , right-hand panels). Higher magnification of the membrane BTK PH showed that the fluorescence intensity of BTK PH at the leading edge was only slightly reduced after 60 s of LY294002 treatment ( Figure 3G ). After 120 s of LY294002 treatment, the translocation of BTK PH was reduced to 10 % of maximal levels, whereas the carrier-treated cells remained at ∼ 60 % of maximal levels ( Figure 3H ). Consistent with previous findings [24] , our results indicated that the half-life of membrane PtdIns(3,4,5)P 3 as detected in the PH-domain-dependent assay was approx. 60 s.
Overexpression of BTK PH delays membrane PtdIns(3,4,5)P 3 hydrolysis
To determine the reason for the relatively low rate of decay of membrane-targeted BTK PH in LY294002-treated cells, we measured the rate of PtdIns(3,4,5)P 3 turnover using the antiPtdIns(3,4,5)P 3 immunostaining method in cells transfected with the BTK PH construct. The cells were stimulated with EGF for 1 min, treated with LY294002 or carrier in the continued presence of EGF for various times, and fixed and stained with anti-PtdIns(3,4,5)P 3 antibody. The maximal signal in BTK PH transfected after 1 min of EGF stimulation was higher than in untransfected cells (Figure 4A) , consistent with the sequestration of PtdIns(3,4,5)P 3 by the overexpressed PH domain. Furthermore, Figure 5 PTEN is inhibited by PH domains from GRP-1 PTEN activity was measured in the presence of recombinant PH domains from GRP-1 or dynamin, using the Malachite Green assay kit from Echelon Biosciences.
anti-PtdIns(3,4,5)P 3 staining in cells transfected with BTK PH was relatively insensitive to LY294002 treatment ( Figure 4B ). This was in marked contrast with non-transfected cells, where leading-edge PtdIns(3,4,5)P 3 staining was virtually undetectable within 10 s of LY294002 treatment. Quantification of leadingedge fluorescence showed that PtdIns(3,4,5)P 3 levels in BTK PHtransfected cells remained at ∼ 60-70 % above basal levels after treatment with either DMSO or LY294002, whereas membrane PtdIns(3,4,5)P 3 levels in non-transfected cells fell to ∼ 10 % after 10 s of LY294002 treatment. These results suggest that overexpression of BTK PH alters the kinetics of PtdIns(3,4,5)P 3 hydrolysis.
To test the hypothesis that the binding of BTK PH to PtdIns(3,4,5)P 3 could inhibit PTEN-mediated hydrolysis in vivo, we measured the PTEN-catalysed hydrolysis of short-chain (di-C 8 ) PtdIns(3,4,5)P 3 in the presence of recombinant PH domain from GRP-1 ( GRP-1 PH), which, like BTK, binds specifically to PtdIns(3,4,5)P 3 [12, 13] , or dynamin PH, which binds preferentially to PtdIns(4,5)P 2 [9] . Whereas dynamin PH had little affect on PTEN activity, significant inhibition was observed with GRP-1 PH ( Figure 5 ). Thus PH domains that bind PtdIns(3,4,5)P 3 inhibit the hydrolysis of this lipid both in vitro and in cells.
DISCUSSION
We have examined the kinetics of PtdIns(3,4,5)P 3 synthesis and turnover in EGF-stimulated MTLn3 cells, where class IA PI3Ks are required for barbed-end formation and protrusion [22] . Membrane PtdIns(3,4,5)P 3 levels increase rapidly after EGF stimulation and remain elevated for up to 3 min in EGF-stimulated cells. Furthermore, we show that membrane PtdIns(3,4,5)P 3 turnover is extremely rapid, with a half-life of less than 10 s. Given the speed of PtdIns(3,4,5)P 3 turnover, the kinetics of PtdIns(3,4,5)P 3 levels in the plasma membrane directly reflect the kinetics of PI3K activity. Thus the sustained elevation of leadingedge PtdIns(3,4,5)P 3 production in EGF-stimulated cells requires persistent PI3K activation at the leading edge of protruding cells.
Recent advances in defining the mechanisms that drive chemotaxis have focused on the asymmetric production of PtdIns(3,4,5)P 3 at the leading edge. These studies have widely used the PH-domain-containing proteins to detect membrane localization of phosphoinositide lipids [25, 26] . Although the use of GFP-linked PH domain probes is clearly advantageous for live-image microscopy, our data suggest that the kinetics of PtdIns(3,4,5)P 3 accumulation in live-cell PH-domain assays may be inaccurate. When we compared directly measurements of PtdIns(3,4,5)P 3 turnover using different methods, we found that PH-domain-dependent assays showed a low rate of PtdIns(3,4,5)P 3 turnover, with a half-life of approx. 60 s. This is consistent with a previous study in which the half-life of PtdIns(3,4,5)P 3 turnover in insulin-stimulated NIH 3T3-L1 cells was estimated to be 1 min, based on the membrane translocation of an Akt PH (PH domain of Akt)-CFP (cyan fluorescent protein) construct [24] . Our data suggest that PH-domain-dependent assays overestimate the lifetime of PtdIns(3,4,5)P 3 relative to antiPtdIns(3,4,5)P 3 immunostaining assays. This is likely to be the explanation for the fact that PH-domain-based assays show that PtdIns(3,4,5)P 3 levels remain elevated for over 5 min in EGFstimulated cells, whereas anti-PtdIns(3,4,5)P 3 staining shows that PtdIns(3,4,5)P 3 returns to basal levels by 5 min. Interestingly, the BTK PH probe responded to EGF stimulation with similar initial kinetics to that seen in anti-PtdIns(3,4,5)P 3 -immunostained cells (Figure 2 ). These results suggest that, even though the protective effects of the PH domain probes are likely to distort the decay rates of PtdIns(3,4,5)P 3 signalling, these probes may accurately measure initial rates of PtdIns(3,4,5)P 3 accumulation. It should be noted that these problems do not apply to the previously described use of PH domains for electron microscopic analysis of phosphoinositide localization and abundance [27] [28] [29] .
Although expression of PH domains may alter the apparent kinetics of lipid accumulation/degradation, they may be a less perturbing and more accurate method of analysing the spatial distribution of membrane phosphoinositides. As noted by Downes et al. [27] , membrane lipids are less likely to be immobilized than membrane proteins by aldehyde-based fixation methods. This raises the question of potential lateral diffusion of membranebound PtdIns(3,4,5)P 3 using the antibody-based method. Furthermore, the fixation method used here requires the presence of saponin (0.15 mg/ml). Triton concentrations as low as 0.0 025 % induce clustering of PtdIns(4,5)P 2 detectable by FRET (fluorescence resonance energy transfer), with visible clustering observed at 0.005 % Triton [30] . However, aldehyde fixation would certainly block membrane trafficking and changes in cell spreading, as well as production of new PtdIns(3,4,5)P 3 . In the kinetic studies described in the present paper, PtdIns(3,4,5)P 3 was quantified by measuring total fluorescence intensity in 0.2 μm concentric slices in from the cell perimeter. Although detergentinduced lipid clustering might affect measurements from a subjectively defined region of interest, it would be unlikely to affect the total fluorescence in concentric slices, which sample the entire cell periphery. Furthermore, samples at 1 min [the peak of PtdIns(3,4,5)P 3 accumulation] were subjected to the same treatment as samples from later times, suggesting that the rapid loss of PtdIns(3,4,5)P 3 staining in LY294002-treated cells is not due to diffusion of the lipid during processing.
A final difference between the two methods is the availability of the membrane PtdIns(3,4,5)P 3 to the probe. If membrane PtdIns(3,4,5)P 3 was rapidly bound by effector proteins, this could limit its detection by anti-PtdIns(3,4,5)P 3 antibodies. Intracellular PH domain probes would presumably be less subject to this constraint, as they would compete with signalling molecules for PtdIns(3,4,5)P 3 during signal generation. However, immunodetection of membrane PtdIns(3,4,5)P 3 after 1 min of EGF stimulation is robust, even though this is also the time of peak PH domain recruitment (based on the kinetics of BTK PH and endogenous Akt translocation). Furthermore, maximal antiPtdIns(3,4,5)P 3 staining is increased, not decreased, in cells expressing BTK PH. These data would suggest that antibody binding is not limited by effector binding. Presumably, PH-domainassociated PtdIns(3,4,5)P 3 can be detected by subsequent antiPtdIns(3,4,5)P 3 staining, perhaps due to structural alterations in the PH domain during fixation that lead to a reduced affinity for PtdIns(3,4,5)P 3 .
What is the mechanism for the prolonged half-life of PtdIns(3,4,5)P 3 as detected by BTK PH membrane recruitment? The simplest explanation is that PH-domain binding interferes with the accessibility of membrane-bound PtdIns(3,4,5)P 3 to lipid phosphatases. This model, in which the inositol headgroup of PtdIns(3,4,5)P 3 is sequestered by the PH domain, is consistent with our in vitro data showing that PH domains from GRP-1 inhibit PTEN dephosphorylation of PtdIns(3,4,5)P 3 . This is in contrast with experiments using PLCδ PH to measure plasma membrane PtdIns(4,5)P 2 levels; in this case, the probe was shown to cycle rapidly on and off the membrane, suggesting that it was unlikely to sequester its lipid target [31] . The published binding affinities of PLCδ PH for PtdIns(4,5)P 2 and BTK PH for PtdIns(3,4,5)P 3 (K d 1.7 compared with 0.8 μM) are similar, although the measurements were made using different methods [8, 32] . Thus, based on lipidbinding affinity alone, one would predict similarly high on/off rates for the BTK PH. It is possible that, for BTK PH, hydrophobic residues of the PH domain that interact with the membrane may increase the effective binding affinity for PtdIns(3,4,5)P 3 in the plasma membrane [11] .
An alternative explanation for slower PtdIns(3,4,5)P 3 turnover as measured by BTK PH is that the in vitro phosphoinositide binding by the PH domains may not correlate with their behaviour in vivo [11] . For example, the recombinant Sos (Son of sevenless) PH domain binds selectively to PtdIns(4,5)P 2 lipid vesicles in an in vitro assay, but the membrane localization of the Sos PH domain appears to be PtdIns(4,5)P 2 -independent in vivo [33] . Similarly, although a critical role for PtdIns(4,5)P 2 in the secretory pathway is well established biochemically, PLCδ1 PH-GFP probes fail to recognize PtdIns(4,5)P 2 in the Golgi and secretory vesicles [11] . Finally, it is important to emphasize that PH domains are capable of protein-protein interactions [34] . Mutagenesis studies of PH domains have shown that the inhibitory effect of PH-domain expression can be independent of their lipid-binding properties, suggesting that PH domains might interact with other proteins [34, 35] .
Interestingly, our results show that overexpression of BTK PH delays membrane PtdIns(3,4,5)P 3 hydrolysis in both the BTK PH translocation (Figures 3E-3H ) and anti-PtdIns(3,4,5)P 3 staining (Figure 4 ) assays. Expression of BTK PH is higher than that of endogenous PH-domain-containing proteins, and therefore could lead to the sequestration of PtdIns(3,4,5)P 3 . Alternatively, we cannot rule out the possibility that overexpression of BTK PH in cells in fact alters the hydrolysis rate of endogenous PtdIns(3,4,5)P 3 by interfering with EGF signalling, leading to an inhibition of cellular lipid phosphatase activity or expression. Consistent with this latter explanation, a recent study showed that overexpression of isolated PH domains can disrupt PtdIns(3,4,5)P 3 -regulated cellular processes [35] . Similarly, overexpression of dynamin-1 PH suppresses the process of rapid endocytosis [10] , and expression of BTK PH inhibits Akt activation [35] . In summary, the use of anti-PtdIns(3,4,5)P 3 immunostaining for measuring PtdIns(3,4,5)P 3 production has both advantages and disadvantages relative to live-cell PH-domain-mediated techniques. Immunofluorescence analysis of PtdIns(3,4,5)P 3 using anti-PtdIns(3,4,5)P 3 antibodies eliminates the possibility of perturbing effects of PH-domain overexpression, and may more accurately reflect the kinetics of endogenous PtdIns(3,4,5)P 3 levels. We have used this method to define the kinetics of PtdIns(3,4,5)P 3 accumulation in EGF-stimulated carcinoma cells, and we have demonstrated an extremely high turnover rate for PtdIns(3,4,5)P 3 . On the other hand, the possibility of lipid diffusion in fixed cells, and detergent-induced lipid clustering, may limit the spatial resolution of anti-PtdIns(3,4,5)P 3 staining. Nonetheless, our data support the use of this method as a valuable
